Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13184
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPongsawat S.
dc.contributor.authorJaruchotiratanasakul N.
dc.contributor.authorNilbu-Nga C.
dc.contributor.authorPradidarcheep W.
dc.date.accessioned2021-04-05T03:22:39Z-
dc.date.available2021-04-05T03:22:39Z-
dc.date.issued2017
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85075013073
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13184-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85075013073&partnerID=40&md5=8c7134840f895da96b850ae6795def93
dc.description.abstractBackground: The pericarp extract of mangosteen (Garicinia mangostana) Linn, alpha-mangostin, is known to have beneficial effects on the body which includes anti-inflammatory, as well as anti-diabetic properties. Extramedullary hematopoiesis is the process whereby blood cellular components are formed outside the bone marrow under stressful conditions. Objective: To evaluate the effects of subacute toxicity induced by alpha-mangostin in rat spleen. Material and Method: A total of 40 Wistar rats were used to study histopathological changes in the spleen after being exposed to alpha-mangostin for one month. The rats were equally divided into four groups: treated male (n = 10); treated female (n = 10); control male (n = 10); and control female (n = 10). The treated group received alpha-mangostin pericarp extract diluted in 0.1% carboxymethylcellulose (0.1% CMC) in a concentration of 100 mg/5 ml, and 100 mg/kg/day alpha-mangostin was introduced to the rats via intra-peritoneal injection. The control group received 0.1% CMC five days per week for one month as standard treatment. Splenic tissues were collected at the end of the study period. Paraffin sections were examined by H&E and immunohistochemical stainings. Body weight was measured before and after the intervention for all groups. Results: After exposure to alpha-mangostin, the treated groups showed increased platelet formation, myeloid progenitor cells, and megakaryocyte in the spleen as well as decrease in the body weight of male rats when compared to the control groups. Immunohistochemical study confirmed that the newly formed blood cells were from myeloid and erythroid precursor cells. Conclusion: Exposure to high dose of alpha-mangostin marked the presence of extramedullary hematopoiesis which is the formation of blood cellular components outside the bone marrow. © 2017 Medical Association of Thailand. All rights reserved.
dc.subjectalpha mangostin
dc.subjectphytochemical
dc.subjectunclassified drug
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectantidiabetic activity
dc.subjectantiinflammatory activity
dc.subjectArticle
dc.subjectbody weight
dc.subjectbone marrow
dc.subjectcontrolled study
dc.subjectdrug megadose
dc.subjectextramedullary hematopoiesis
dc.subjectfemale
dc.subjectGarcinia mangostana
dc.subjecthigh performance liquid chromatography
dc.subjecthistopathology
dc.subjectimmunohistochemistry
dc.subjectmale
dc.subjectmegakaryocyte
dc.subjectmyeloid progenitor cell
dc.subjectnonhuman
dc.subjectrat
dc.subjectspleen
dc.subjectthrombocytopoiesis
dc.subjecttoxicity
dc.titleExtramedullary hematopoiesis in rat spleen after exposure to high doses of alpha-mangostin
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 100, No.10 (2017), p.S185-S194
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.